Filing Details

Accession Number:
0001209191-21-008341
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-05 20:25:03
Reporting Period:
2021-02-03
Accepted Time:
2021-02-05 20:25:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Healthcare Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632835 S. Michael Cuffe One Park Plaza
Nashville TN 37203
President-Physician Services No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-03 20,490 $69.58 56,321 No 4 M Direct
Common Stock Acquisiton 2021-02-03 17,000 $81.96 73,321 No 4 M Direct
Common Stock Disposition 2021-02-03 23,772 $173.12 49,549 No 4 F Direct
Common Stock Disposition 2021-02-03 7,574 $171.17 41,975 No 4 S Direct
Common Stock Disposition 2021-02-05 13,718 $176.22 28,257 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Right Disposition 2021-02-03 20,490 $0.00 20,490 $69.58
Common Stock Stock Appreciation Right Disposition 2021-02-03 17,000 $0.00 17,000 $81.96
Common Stock Stock Appreciation Right Acquisiton 2021-02-03 20,920 $0.00 20,920 $173.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-01-29 No 4 M Direct
5,930 2027-02-01 No 4 M Direct
20,920 2022-02-03 2031-02-03 No 4 A Direct
Footnotes
  1. Includes 2,072.2542 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.90 to $171.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.00 to $176.79, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
  5. The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
  6. The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.